Support the fact-based journalism you rely on with a donation to Marketplace today. Give Now!

Protecting yourself from COVID-19 these days is hard. And it comes at a cost.

Mar 20, 2024
Governments and businesses need to invest in ways to prevent transmission, experts say, instead of leaving people on their own.
"We cannot rely on masking forever. We cannot ask people, even immunocompromised people, to mask for the next 100 years," says Dr. Ziyad Al-Aly, a clinical epidemiologist.  Above, people with long COVID symptoms sit in on a Senate hearing about the condition.
Drew Angerer/Getty Images

Evusheld offers vulnerable Americans protection from COVID. But getting it has been complicated.

May 24, 2022
Scarcity and a lack of outreach has left millions of immunocompromised Americans without access to the treatment.
The Biden administration ordered 1.7 million doses of Evusheld, but around three-quarters of those may have gone unused, according to some estimates.
Jonathan Nackstrand/AFP via Getty Images